Meet the three compounds
Dedicated introductions to the identities behind the current pen listings.
Understand retatrutide’s receptor targets, how to read its research literature and what the 40mg pen listing describes.
1 min read Tirzepatide in focus: identity, evidence and the 60mg formatExplore tirzepatide’s dual receptor profile and distinguish published research findings from the specification of a 60mg pen.
1 min read Cagrilintide: the amylin connection and the 10mg listingLearn why cagrilintide is described as an amylin analogue and how its research background relates to the 10mg reference listing.
1 min readPut the differences in context
Compare receptor systems and specifications without treating unlike materials as equivalent.
Compare the receptor profiles of retatrutide and tirzepatide without confusing target coverage, container strength or study outcomes.
1 min read Tirzepatide and cagrilintide: compare identities before quantitiesSee how tirzepatide and cagrilintide differ in molecular background, receptor context and the meaning of their pen specifications.
1 min readThis library supports laboratory reference and documentation. It does not provide clinical, veterinary or legal advice or instructions for administration. Review the Research-Use-Only Policy and Terms of Supply.